DermTech

John Dobak, President and CEO
John Dobak, President and CEO
USA | Funding: $259.9M (+)

Website: https://dermtech.com/

DermTech is the global leader in molecular dermatology, bringing precision medicine to the diagnosis and treatment of skin disease. We market and develop products that facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments.